Yang, Jeng-HowJeng-HowYangWang, Ping-HuaiPing-HuaiWangPan, Sheng-WeiSheng-WeiPanWei, Yu-FengYu-FengWeiCHUNG-YU CHENLee, Ho-ShengHo-ShengLeeCHIN-CHUNG SHUWu, Ting-ShuTing-ShuWu2022-10-272022-10-272022-04-252079-6382https://scholars.lib.ntu.edu.tw/handle/123456789/624014The contemporary guidelines have recommended multiple antimicrobial therapies along with oral macrolides for the treatment of Mycobacterium abscessus complex lung disease (MABC-LD). However, there is little evidence supporting the parenteral tigecycline-containing regimens against MABC-LD. Therefore, we conducted this study to evaluate the effect of intravenous tigecycline-containing regimens on the treatment of MABC-LD.enMycobacterium abscessus complex; amikacin; lung disease; tigecycline; treatment outcome[SDGs]SDG3journal article10.3390/antibiotics11050571356252152-s2.0-85129869282WOS:000801473900001https://api.elsevier.com/content/abstract/scopus_id/85129869282